209 related articles for article (PubMed ID: 36538310)
21. [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].
Yang JF; Han JS; Zhu FL; Wang YT; Yao Y; Qiao J
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):487-91. PubMed ID: 23141156
[TBL] [Abstract][Full Text] [Related]
22. Timing of Office-Based Pessary Care: A Randomized Controlled Trial.
Propst K; Mellen C; O'Sullivan DM; Tulikangas PK
Obstet Gynecol; 2020 Jan; 135(1):100-105. PubMed ID: 31809432
[TBL] [Abstract][Full Text] [Related]
23. Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.
Hemming C; Constable L; Goulao B; Kilonzo M; Boyers D; Elders A; Cooper K; Smith A; Freeman R; Breeman S; McDonald A; Hagen S; Montgomery I; Norrie J; Glazener C
Health Technol Assess; 2020 Mar; 24(13):1-220. PubMed ID: 32138809
[TBL] [Abstract][Full Text] [Related]
24. Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial.
Jelovsek JE; Barber MD; Brubaker L; Norton P; Gantz M; Richter HE; Weidner A; Menefee S; Schaffer J; Pugh N; Meikle S;
JAMA; 2018 Apr; 319(15):1554-1565. PubMed ID: 29677302
[TBL] [Abstract][Full Text] [Related]
25. Comparison of outcomes between pessary use and surgery for symptomatic pelvic organ prolapse: A prospective self-controlled study.
Linder BJ; Gebhart JB; Weaver AL; Fick FR; Harvey-Springer RR; Trabuco EC; Klingele CJ; Occhino JA
Investig Clin Urol; 2022 Mar; 63(2):214-220. PubMed ID: 35244996
[TBL] [Abstract][Full Text] [Related]
26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
27. Long-term adherence to pessary use in women with pelvic organ prolapse: A retrospective cohort study.
Koch M; Carlin G; Lange S; Umek W; Krall C; Bodner-Adler B
Maturitas; 2023 Dec; 178():107828. PubMed ID: 37659128
[TBL] [Abstract][Full Text] [Related]
28. Goal attainment after treatment in patients with symptomatic pelvic organ prolapse.
Mamik MM; Rogers RG; Qualls CR; Komesu YM
Am J Obstet Gynecol; 2013 Nov; 209(5):488.e1-5. PubMed ID: 23770473
[TBL] [Abstract][Full Text] [Related]
29. Can we predict continued pessary use as primary treatment in women with symptomatic pelvic organ prolapse (POP)? A prospective cohort study.
Thys S; Hakvoort R; Milani A; Roovers JP; Vollebregt A
Int Urogynecol J; 2021 Aug; 32(8):2159-2167. PubMed ID: 34002267
[TBL] [Abstract][Full Text] [Related]
30. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
[TBL] [Abstract][Full Text] [Related]
31. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse.
Abdool Z; Thakar R; Sultan AH; Oliver RS
Int Urogynecol J; 2011 Mar; 22(3):273-8. PubMed ID: 21161179
[TBL] [Abstract][Full Text] [Related]
33. Transition to surgery after pessary among female Medicare beneficiaries with pelvic organ prolapse.
Meister MRL; Osazuwa-Peters OL; Lowder JL; Handa VL
Am J Obstet Gynecol; 2023 May; 228(5):559.e1-559.e9. PubMed ID: 36627074
[TBL] [Abstract][Full Text] [Related]
34. Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse.
Manchana T
Arch Gynecol Obstet; 2024 May; 309(5):2203-2209. PubMed ID: 38189963
[TBL] [Abstract][Full Text] [Related]
35. Pelvic Organ Prolapse Severity and Genital Hiatus Size With Long-Term Pessary Use.
Boyd SS; Subramanian D; Propst K; O'Sullivan D; Tulikangas P
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e360-e362. PubMed ID: 32910077
[TBL] [Abstract][Full Text] [Related]
36. A tailored flexible vaginal pessary treatment for pelvic organ prolapse in older women.
Gold RS; Baruch Y; Amir H; Gordon D; Groutz A
J Am Geriatr Soc; 2021 Sep; 69(9):2518-2523. PubMed ID: 33979457
[TBL] [Abstract][Full Text] [Related]
37. Do patients prefer a pessary or surgery as primary treatment for pelvic organ prolapse.
Thys SD; Roovers JP; Geomini PM; Bongers MY
Gynecol Obstet Invest; 2012; 74(1):6-12. PubMed ID: 22759810
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Self-cut vs Mesh-Kit Titanium-Coated Polypropylene Mesh for Transvaginal Treatment of Severe Pelvic Organ Prolapse: A Multicenter Randomized Noninferiority Clinical Trial.
Chen J; Yu J; Morse A; Tao G; Gong J; Wang B; Wang Y; Ababaikeli G; Jiang X; Liu P; Zhang X; Nisier H; Wang P; Fünfgeld C; Huang K; Zhang H; Sun X; Zhu L
JAMA Netw Open; 2022 Sep; 5(9):e2231869. PubMed ID: 36112377
[TBL] [Abstract][Full Text] [Related]
39. [Long-term effectiveness of transvaginal high uterosacral ligament suspension].
Duan L; Lu YX; Shen WJ; Liu X; Liu JX; Zhang YH; Ge J; Zhao Y; Niu K; Wang WY
Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):363-368. PubMed ID: 28647957
[No Abstract] [Full Text] [Related]
40. Generic Health-Related Quality of Life in Patients Seeking Care for Pelvic Organ Prolapse.
Bradley CS; Brown HW; Shippey SS; Gutman RE; Andy UU; Yurteri-Kaplan LA; Kudish B; Mehr A; O'Boyle A; Foster RT; Anger JT; Ten Eyck P; Moalli PA;
Female Pelvic Med Reconstr Surg; 2021 Jun; 27(6):337-343. PubMed ID: 34080581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
